- Idex 1Q Net Sales met the estimated sales at $800.5 million, slightly lower than the $807.9 million estimate.
- The adjusted gross margin was at 45%, higher than the estimated 42.6%.
- For the second quarter, organic sales are projected to decline 2% to 3% compared to the same period last year.
- Full year organic sales growth is estimated to be between 0% and 2% compared to the previous year.
- The IDEX teams, according to Eric D. Ashleman, CEO and President of IDEX Corporation, have delivered solid results in the first quarter by expanding margins in the Fluid & Metering Technologies and Fire & Safety / Diversified Products segments, and also driving strong cash flow across the company.
- Resources will be deployed to build momentum in these advantaged markets throughout the remainder of the year.
- The company has 8 buys, 7 holds, and no sells according to recent assessments.
A look at Idex Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Idex Corp shows a promising long-term outlook. With a strong focus on Growth and Momentum categories, the company is positioned well for expansion and market performance. Idex Corp‘s emphasis on innovation and forward-thinking strategies bodes well for its future prospects in the industry.
Additionally, Idex Corp demonstrates a fair level of Resilience and Value while maintaining a moderate score in Dividend. This suggests a balanced approach to financial stability and shareholder returns. Overall, considering its diversified product portfolio and global market presence, Idex Corp appears to be on a positive trajectory for sustained growth and success.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
